大规模医疗后送以减轻重症监护负担:COVID-19患者大规模转运(TRANSCOV)队列研究结果
本研究为多中心回顾性队列研究,纳入285例转运患者和667例对照(未转运)患者,对照与转运患者同时(±2天)入住同一原ICU且在转运日期后5天仍存活。比较两组28天ICU病死率和ICU期间临床事件。结果显示转运患者调整后发病率比为0.14(95%CI 0.10-0.19),病死率约低7倍;转运患者ICU停留更长,谵妄、精神障碍和神经肌肉阻滞暴露更频繁,而对照组急性肾损伤更频繁(51.5% vs 37.7%,P<.0001)。作者认为,尽管选择较健康患者可能贡献于生存获益,但脱离过度拥挤的护理环境也可能解释转运相关的大幅生存获益;通过减少工作量,大规模转运可能也使留在原ICU的患者受益;尽早组织大规模转运可能是缓解重症监护需求过载影响的适当策略。
要点
- 在ICU超负荷背景下,转运患者28天ICU病死率调整后发病率比为0.14(95%CI 0.10-0.19),约低7倍。
- 转运患者与对照在入ICU时年龄、COVID-19严重程度、合并症和简化急性生理评分II相似,但转运患者体重更轻(81 vs 89 kg,P<.0001)且更自主(64.5% vs 55.0%,P=.01)。
- 转运患者ICU停留更长,谵妄、精神障碍和神经肌肉阻滞暴露更频繁;对照组急性肾损伤更频繁(51.5% vs 37.7%,P<.0001)。
- 作者认为,选择较健康患者可能部分解释生存获益,但脱离过度拥挤环境也可能贡献,且减少工作量可能使留在原ICU的患者受益。
- 作者建议,尽早组织大规模转运可能是缓解重症监护需求过载的适当策略。
适用人群与场景
- 法国COVID-19第一波疫情(2020年春季)期间,同时(±2天)入住同一原ICU且在转运日期后5天仍存活的成人患者;转运患者285例,对照(未转运)患者667例。
研究设计与关键结果
- 多中心回顾性队列研究,纳入285例转运患者和667例对照(未转运)患者,对照与转运患者同时(±2天)入住同一原ICU且在转运日期后5天仍存活。
- 入ICU时两组年龄、COVID-19严重程度、合并症和简化急性生理评分II相似,但转运患者体重更轻(81 vs 89 kg,P<.0001)且更自主(64.5% vs 55.0%,P=.01)。
- 28天ICU病死率:转运患者调整后发病率比0.14(95%CI 0.10-0.19),约低7倍。
- 转运患者ICU停留更长,谵妄、精神障碍和神经肌肉阻滞暴露更频繁;对照组急性肾损伤更频繁(51.5% vs 37.7%,P<.0001)。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管选择较健康患者可能贡献于生存获益,但脱离过度拥挤的护理环境也可能解释转运相关的大幅生存获益。
- 作者认为,通过减少工作量,大规模转运可能也使留在原ICU的患者受益。
- 作者建议,尽早组织大规模转运可能是缓解重症监护需求过载影响的适当策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In a context of overwhelming demand, mass transfers between ICUs were organized in France during the first COVID-19 epidemic wave (spring 2020). According to early reports, transferred patients experienced a 3- to 4-fold lower ICU case fatality. It is not known whether this difference stems only from the selection of healthier patients for transfer.
RESEARCH QUESTION: Is the 28-day ICU case fatality of transferred patients different from that of matched control (not transferred) patients?
STUDY DESIGN AND METHODS: This was a multicenter retrospective cohort study that included 285 transferred patients and 667 control (not transferred) patients admitted simultaneously (± 2 days) to the same origin ICU and were alive 5 days after the transfer date. The 28-day ICU case fatality and clinical events during ICU stay were compared in transferred and control patients.
RESULTS: At ICU admission, age, COVID-19 severity, comorbidities, and Simplified Acute Physiology Score II were similar, but transferred patients were lighter (81 vs 89 kg, P < .0001) and more autonomous than the matched control patients (64.5% vs 55.0%, P = .01). Case fatality was approximately 7-fold lower in transferred patients (adjusted incidence rate ratio, 0.14; 95% CI, 0.10-0.19). ICU stay was longer and delirium, psychiatric disorders, and neuromuscular blockade exposure were more frequent in transferred patients than control patients. Conversely, acute kidney injury was more frequent in control patients (51.5% vs 37.7%, P < .0001).
INTERPRETATION: Although the selection of healthier patients likely contributed to better survival, removal from an overcrowded care environment probably also explains the large survival benefit associated with transfer. By reducing workload, mass transfers might have also benefited patients who remained in origin ICUs. Organizing mass transfers as early as possible may be an appropriate strategy for mitigating the impact of an overwhelming intensive care demand.
参考来源
- Grimaud O, Leray E, Bayat S, et al. Mass Medical Evacuations to Decrease the Intensive Care Burden: Results From the Mass Transfer of COVID-19 Patients (TRANSCOV) Cohort Study. Chest. 2025. PMID: 40939929. doi:10.1016/j.chest.2025.08.023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。